We found that Arg2 is the main metaboliser in 88% of MB tumours and that these were deficient in recycling enzymes ASL, ASS1, and OTC in 79%, 88%, and 85% of cases (Figure 4, supplementary table 3). Here, OTC is linked to neoplasm.